Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001069095 | SCV001234241 | pathogenic | Mucopolysaccharidosis type 6 | 2019-03-20 | criteria provided, single submitter | clinical testing | Loss-of-function variants in ARSB are known to be pathogenic (PMID: 17458871, 22133300). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with ARSB-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Glu346*) in the ARSB gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. |